Related Experiment Video
Updated: Jun 9, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Perioperative Inflammation and Functional Recovery after Surgical Aortic and Mitral Valve Replacement: A Prospective
Navneet Kumar Srivastva1, Ajitesh P Jain1, Dharmendra Kumar Srivastava1
1Department of Cardiovascular and Thoracic Surgery, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
Background:
Cardiac valve surgery induces systemic inflammation and variable ventricular recovery. Whether inflammatory responses differ by prosthesis type and influence clinical or functional outcomes remains unclear.
Materials And Methods:
In this prospective observational study, 100 adults undergoing aortic valve replacement (AVR) or mitral valve replacement (MVR) received either mechanical (n = 50) or bioprosthetic (n = 50) valves. Biochemical and inflammatory markers were measured preoperatively, on postoperative day (POD) 1, and on POD 6. Early clinical outcomes were recorded. Transthoracic echocardiography was performed at baseline and 6 months.
Results:
Baseline characteristics were comparable between groups (age: 49.96 ± 9.88 years; baseline left ventricular ejection fraction [LVEF]: 48.97 ± 9.00%; EuroSCORE II: 3.64 ± 1.74). All patients exhibited a marked inflammatory surge on POD 1, with C-reactive protein increasing from 4.04 (2.83-5.33) to 59.98 (45.50-74.05) mg/L and interleukin-6 from 7.08 (5.91-8.28) to 118.53 (95.25-141.06) pg/mL, followed by partial normalization by day 6 (all P < 0.001). Inflammatory trajectories did not differ by prosthesis type. Early outcomes included atrial fibrillation in 32%, acute kidney injury in 16.0%, and 30-day mortality in 6.0%, without significant valve-group differences. At 6 months, mechanical valves demonstrated lower mean transvalvular gradients (5.77 ± 4.69 vs. 10.20 ± 5.18 mmHg; P = 0.001) and greater improvement in LVEF (ΔLVEF: 5.68 ± 2.99 vs. 3.83 ± 3.08%; P = 0.003). AVR (β = 2.80; P < 0.001) and mechanical prostheses (β = 2.50; P < 0.001) independently predicted greater ΔLVEF. Serum lactate predicted 30-day mortality (area under the curve: 0.846).
Conclusions:
Perioperative inflammation is substantial but transient and unrelated to prosthesis type. Functional recovery is driven by valve position and prosthesis hemodynamics, with mechanical AVR conferring superior mid-term ventricular improvement.
Related Concept Videos
Aneurysm IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Mitral Stenosis IV: Nursing Management
Mitral Stenosis III: Medical Management
Aortic Regurgitation III: Medical Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management

